| Literature DB >> 24626166 |
Melissa J Caimano1, Sathesh K Sivasankaran2, Anna Allard3, Daniel Hurley4, Karsten Hokamp5, André A Grassmann6, Jay C D Hinton7, Jarlath E Nally8.
Abstract
Leptospirosis, an emerging zoonotic disease with worldwide distribution, is caused by spirochetes belonging to the genus Leptospira. More than 500,000 cases of severe leptospirosis are reported annually, with >10% of these being fatal. Leptospires can survive for weeks in suitably moist conditions before encountering a new host. Reservoir hosts, typically rodents, exhibit little to no signs of disease but shed large numbers of organisms in their urine. Transmission occurs when mucosal surfaces or abraded skin come into contact with infected urine or urine-contaminated water or soil. In humans, leptospires can cause a variety of clinical manifestations, ranging from asymptomatic or mild fever to severe icteric (Weil's) disease and pulmonary haemorrhage. Currently, little is known about how Leptospira persist within a reservoir host. Prior in vitro studies have suggested that leptospires alter their transcriptomic and proteomic profiles in response to environmental signals encountered during mammalian infection. However, no study has examined gene expression by leptospires within a mammalian host-adapted state. To obtain a more faithful representation of how leptospires respond to host-derived signals, we used RNA-Seq to compare the transcriptome of L. interrogans cultivated within dialysis membrane chambers (DMCs) implanted into the peritoneal cavities of rats with that of organisms grown in vitro. In addition to determining the relative expression levels of "core" housekeeping genes under both growth conditions, we identified 166 genes that are differentially-expressed by L. interrogans in vivo. Our analyses highlight physiological aspects of host adaptation by leptospires relating to heme uptake and utilization. We also identified 11 novel non-coding transcripts that are candidate small regulatory RNAs. The DMC model provides a facile system for studying the transcriptional and antigenic changes associated with mammalian host-adaptation, selection of targets for mutagenesis, and the identification of previously unrecognized virulence determinants.Entities:
Mesh:
Year: 2014 PMID: 24626166 PMCID: PMC3953431 DOI: 10.1371/journal.ppat.1004004
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Figure 1Virulent leptospires become mammalian host-adapted during growth within dialysis membrane chambers.
Representative whole cell lysates of leptospires cultivated to late-logarithmic phase in EMJH medium at 30°C in vitro (IV) and within dialysis membrane chambers (DMC) implanted into the peritoneal cavities of female Sprague-Dawley rats. (A) Lysates were loaded according to the numbers of leptospires (5×106 per lane) or total protein (5 µg per lane) and stained with SYPRO Ruby gel stain. Arrows and asterisks are used to highlight examples of polypeptides whose expression appears to be increased or decreased, respectively, within DMCs compared to in vitro. Molecular mass markers are indicated on the left. (B) Immunoblot analyses using rabbit polyclonal antisera directed against Sph2 [34], LipL32 [38] and LipL41 [39]. An arrow is used to indicate a band of the predicted molecular mass for SphH, a second, closely-related sphingomyelinase in L. interrogans recognized by antiserum directed against Sph2 [34], [37].
Summary of RNA-Seq mapping data.
| Library | Total # of Reads | Total # of mapped reads | Uniquely mapped Reads | Chromosome 1 | Chromosome 2 | |||||
| mRNA | ncRNA | rRNA & tRNA | Intergenic | mRNA | ncRNA | Intergenic | ||||
| DMC_1 | 9,150,966 | 8,327,861 (91.01%) | 598,674 (6.54%) | 279,333 (46.66%) | 125,095 (20.90%) | 155,452 (25.97%) | 13,828 (2.31%) | 22,797 (3.81%) | 374 (0.06%) | 1,795 (0.30%) |
| DMC_2 | 7,902,948 | 6,543,759 (82.80%) | 574,766 (7.27%) | 247,398 (43.04%) | 161,761 (28.14%) | 133,152 (23.17%) | 9,997 (1.74%) | 20,822 (3.62%) | 382 (0.07%) | 1,254 (0.22%) |
| DMC_3 | 14,089,133 | 11,125,795 (78.97%) | 1,151,053 (8.17%) | 589,345 (51.20%) | 240,121 (20.86%) | 235,839 (20.49%) | 33,601 (2.92%) | 46,718 (4.06%) | 1,136 (0.10%) | 4,293 (0.37%) |
| 30°C_1 | 9,562,316 | 8,997,777 (94.10%) | 870,275 (9.10%) | 482,828 (55.48%) | 129,770 (14.91%) | 192,490 (22.12%) | 20,249 (2.33%) | 41,187 (4.73%) | 770 (0.09%) | 2,981 (0.34%) |
| 30°C_2 | 11,642,652 | 10,702,058 (91.92%) | 842,265 (7.23%) | 456,665 (54.22%) | 113,539 (13.48%) | 201,691 (23.95%) | 20,245 (2.40%) | 45,486 (5.40%) | 918 (0.11%) | 3,721 (0.44%) |
| 30°C_3 | 10,175,557 | 9,462,697 (92.99%) | 805,288 (7.91%) | 441,078 (54.77%) | 109,817 (13.46%) | 186,689 (23.18%) | 21,165 (2.63%) | 42,184 (5.24%) | 809 (0.10%) | 3,546 (0.44%) |
Total number and percentage (in parenthesis) of reads that mapped to the reference genome with 100% accuracy.
Total number and percentage (in parenthesis) of reads that mapped to a single location within the reference genome [11], [12].
Based on the total of uniquely mapped reads for the corresponding sample.
Figure 2Mapping of RNA-Seq reads.
Percentage of uniquely mapping reads from each biological replicate of leptospires cultivated in DMCs or under standard in vitro growth conditions (30°C in EMJH).
L. interrogans sv. Copenhageni genes upregulated in DMCs compared to in vitro.
| Gene ID | Product | Fold (DMC vs IV) | P value (adjusted) | |
|
| ||||
|
| Hypothetical protein | ND @ 30°C | 4.00E-02 | |
|
| Hypothetical protein | 22.78 | 1.19E-18 | |
|
| Hypothetical protein | 21.12 | 2.75E-04 | |
|
| Hypothetical protein | 17.46 | 6.13E-06 | |
|
| Hypothetical protein | 16.76 | 2.65E-13 | |
|
| Hypothetical protein | 10.59 | 4.12E-02 | |
|
| Hypothetical protein | 9.73 | 8.94E-08 | |
|
| Hypothetical protein | 7.14 | 3.40E-10 | |
|
| Hypothetical protein | 6.60 | 2.74E-04 | |
|
| Hypothetical protein | 6.54 | 1.04E-02 | |
|
| Hypothetical protein | 6.20 | 1.93E-02 | |
|
| Hypothetical protein | 6.14 | 2.07E-02 | |
|
| Hypothetical protein | 5.71 | 1.33E-08 | |
|
| Hypothetical protein | 5.61 | 2.65E-02 | |
|
| Hypothetical protein | 4.76 | 5.29E-04 | |
|
| Hypothetical protein | 4.35 | 8.70E-03 | |
|
| Hypothetical protein | 4.27 | 8.69E-07 | |
|
| Hypothetical protein | 4.15 | 8.98E-03 | |
|
| Hypothetical protein | 4.06 | 9.65E-03 | |
|
| Hypothetical protein | 4.03 | 4.56E-02 | |
|
| Hypothetical protein | 4.03 | 2.53E-02 | |
|
| Hypothetical protein | 3.93 | 5.73E-06 | |
|
| Hypothetical protein | 3.77 | 4.53E-03 | |
|
| Hypothetical protein | 3.63 | 5.83E-03 | |
|
| Hypothetical protein | 3.53 | 1.19E-03 | |
|
| Hypothetical protein | 3.32 | 3.07E-03 | |
|
| Hypothetical protein | 3.14 | 3.55E-02 | |
|
| Hypothetical protein | 3.14 | 5.99E-03 | |
|
| Hypothetical protein | 3.09 | 2.12E-02 | |
|
| Hypothetical protein | 2.97 | 2.12E-02 | |
|
| Hypothetical protein | 2.94 | 1.21E-02 | |
|
| Hypothetical protein | 2.86 | 4.53E-02 | |
|
| Hypothetical protein | 2.82 | 4.12E-02 | |
|
| Hypothetical protein | 2.81 | 1.23E-02 | |
|
| Hypothetical protein | 2.74 | 5.31E-03 | |
|
| Hypothetical protein | 2.72 | 2.03E-02 | |
|
|
| Hypothetical protein | 2.67 | 8.81E-03 |
|
| Hypothetical protein | 2.66 | 4.04E-02 | |
|
| Hypothetical protein | 2.66 | 2.24E-02 | |
|
| Hypothetical protein | 2.66 | 3.36E-02 | |
|
| Hypothetical protein | 2.61 | 3.75E-02 | |
|
| Hypothetical protein | 2.53 | 4.28E-02 | |
|
| Hypothetical protein | 2.52 | 2.11E-02 | |
|
| Hypothetical protein with OmpA-like domain | 2.46 | 1.54E-02 | |
|
| Hypothetical protein | 2.43 | 2.67E-02 | |
|
| Hypothetical protein | 2.42 | 3.36E-02 | |
|
| Hypothetical protein | 2.23 | 2.28E-02 | |
|
| Hypothetical protein | 2.08 | 3.02E-02 | |
|
| ||||
|
|
| Lipoprotein | 19.50 | 1.03E-26 |
|
| Lipoprotein | 11.18 | 1.78E-04 | |
|
| Lipoprotein | 7.76 | 2.75E-15 | |
|
|
| Lipoprotein | 6.27 | 8.69E-07 |
|
| Lipoprotein | 5.37 | 4.61E-11 | |
|
| Lipoprotein | 5.34 | 3.09E-09 | |
|
| Lipoprotein | 5.08 | 3.17E-07 | |
|
| Lipoprotein | 4.61 | 9.64E-08 | |
|
|
| Lipoprotein | 3.84 | 1.44E-05 |
|
| Lipoprotein | 3.72 | 1.25E-02 | |
|
| Lipoprotein | 3.64 | 2.07E-04 | |
|
| Lipoprotein | 3.54 | 1.84E-04 | |
|
| Lipoprotein | 3.44 | 2.81E-03 | |
|
| Lipoprotein | 3.31 | 4.81E-04 | |
|
| Lipoprotein | 3.15 | 2.03E-03 | |
|
| Lipoprotein | 2.24 | 2.03E-02 | |
|
| ||||
|
|
| Collagenase precursor | 49.03 | 2.63E-51 |
|
|
| Hemolysin/sphingomyelinase-like protein, Sph2 | 13.92 | 5.13E-26 |
|
|
| Peroxiredoxin | 5.96 | 7.29E-07 |
|
|
|
| 4.57 | 2.03E-02 |
|
|
| Hemolysin/sphingomyelinase-like protein, Sph1 | 4.02 | 1.52E-05 |
|
| Cytochrome c peroxidase | 4.23 | 1.04E-05 | |
|
|
| Hemolysin/sphingomyelinase-like protein, Sph3 | 3.57 | 1.99E-02 |
|
|
| Virulence-associated protein | 2.90 | 2.66E-02 |
|
| ||||
|
|
| Flagellar basal body rod protein FlgB | 7.89 | 4.89E-16 |
|
|
| Flagellin protein | 3.95 | 1.50E-02 |
|
|
| Flagellar basal body rod protein FlgC | 3.91 | 2.12E-05 |
|
|
| Flagellum-specific muramidase | 3.89 | 7.28E-03 |
|
|
| Flagellar hook-basal body protein FliE | 3.16 | 1.87E-03 |
|
|
| Flagellar L-ring protein precursor | 2.66 | 3.03E-02 |
|
|
| Flagellar protein | 2.37 | 3.72E-02 |
|
| ||||
|
| TetR family transcriptional regulator | 5.64 | 3.65E-05 | |
|
| DeoR family transcriptional regulator | 4.42 | 3.08E-03 | |
|
|
| Fur family transcriptional regulator | 3.83 | 7.84E-04 |
|
| Histidine kinase response regulator hybrid protein | 3.36 | 1.04E-03 | |
|
| EAL-type diguanylate phosphodiesterase | 3.23 | 2.11E-03 | |
|
| ArsR family transcriptional regulator | 3.11 | 7.39E-03 | |
|
| Cyclic nucleotide binding protein | 2.41 | 4.73E-02 | |
|
| ||||
|
|
| Fatty acid desaturase | 6.72 | 2.98E-11 |
|
| Glutathione S-transferase | 4.00 | 2.59E-02 | |
|
|
| Alkaline phosphatase | 3.21 | 6.13E-04 |
|
|
| Dephospho-CoA kinase | 3.20 | 1.79E-02 |
|
|
| Heme oxygenase | 3.06 | 3.35E-03 |
|
| Glutaconate CoA transferase-like protein | 2.32 | 4.80E-02 | |
|
| Aminotransferase | 2.25 | 1.46E-02 | |
|
| Gly tRNA | 4.69 | 1.69E-02 | |
|
| ||||
|
| TonB-dependent outer membrane receptor | 14.85 | 2.26E-13 | |
|
|
| TonB-dependent outer membrane hemin receptor | 3.46 | 2.23E-02 |
|
| Multidrug-efflux transporter | 2.82 | 4.22E-02 | |
|
|
| Sulfate permease | 2.81 | 4.05E-03 |
|
| ||||
|
|
| Regulator of chromosome condensation | 7.80 | 1.92E-03 |
|
| Site-specific modification DNA-methyltransferase | 5.12 | 6.37E-11 | |
|
| DNA repair protein | 4.55 | 3.80E-02 | |
|
|
| Cell cycle protein | 3.41 | 3.62E-04 |
|
| Exonuclease | 3.31 | 5.86E-03 | |
|
|
| DNA mismatch repair protein | 2.56 | 3.80E-02 |
|
|
| Integrase/recombinase protein | 2.91 | 3.02E-03 |
|
| ||||
|
| OmpA-like peptidoglycan-associated periplasmic protein | 3.79 | 1.00E-03 | |
|
|
| Penicillin-binding protein 3 | 2.46 | 1.99E-02 |
|
| ||||
|
|
| Polyketide synthase | 4.89 | 1.08E-02 |
|
| Rad50-like protein | 3.22 | 4.05E-03 | |
|
|
| 16S ribosomal RNA methyltransferase RsmE | 2.41 | 8.14E-03 |
Gene designations and protein product descriptions are based on those of [11], [12] and the L. interrogans sv. Copenhageni Genome Project database (http://aeg.lbi.ic.unicamp.br/world/lic/), except where indicated.
nnotation based on Setubal et al. [47].
Revised annotation based on bioinformatics.
Leptospiral genes differentially-expressed within DMCs compared to in vitro.
| Genes | No of genes in each category | ||
| Upregulated (%) | Downregulated (%) | Total (%) | |
| Known or predicted function | 45 (41%) | 20 (36%) | 66 (40%) |
| Unknown or poorly characterized function | 65 (59%) | 36 (64%) | 101 (60%) |
|
| 110 | 56 | 166 |
Percentage of genes based on the total number of genes in upregulated or downregulated category.
Percentage of genes based on the total number of differentially-expressed genes.
Hypothetical proteins and uncharacterized lipoproteins.
Figure 3Conservation of L. interrogans sv. Copenhageni Fiocruz L1-130 differentially-expressed genes among virulent and saprophytic Leptospira spp. Protein sequence similarities were determined using GLSEARCH (v. 34.05).
Genomes used for analysis: L. interrogans sv. Lai strain 56601, L. borgpetersenii sv. Hardjo strain L550, L. santarosai sv. Shermani strain LT821; L. licerasiae sv. Varillal strain VAR010; and L. biflexa sv. Patoc strain Patoc1 Ames, respectively. The color coding used in the heat map is as follows: blue, 95–100% identity; green, 90–94% identity; orange, 85–89%; and yellow, 80–84%.
Figure 4Functional categories of genes differentially-expressed by L. interrogans sv Copenhageni strain Fiocruz L1-130 within DMCs.
Functional categories are based on those of [11], [12] and the Leptospira interrogans sv. Copenhageni Genome Project database (http://aeg.lbi.ic.unicamp.br/world/lic/). The number of upregulated (Ups) and downregulated (Down) genes within each category are indicated in red and blue, respectively.
Figure 5IGB viewer of normalized gene expression data for the flagellar genes fliE, flgB and flgC.
Visualization of normalized mapped reads for minus (-) strand of an operon encoding genes fliE, flgB and flgC of the flagellar proximal rod shows increased expression by leptospires cultivated in dialysis membrane chambers (DMC, green) compared to those cultivated in vitro (IV, red). Annotated genes on Chromosome 1 are in blue. The vertical “read count” scale is 0–50.
L. interrogans sv. Copenhageni genes downregulated in DMCs compared to in vitro.
| Gene ID | Product | Fold (DMC vs IV) | P value (adjusted) | |
|
| ||||
|
| Hypothetical protein | −31.35 | 2.28E-09 | |
|
| Hypothetical protein | −29.41 | 4.12E-02 | |
|
| Hypothetical protein | −16.09 | 1.52E-05 | |
|
| Hypothetical protein | −12.71 | 4.24E-15 | |
|
| Hypothetical protein | −11.09 | 2.02E-11 | |
|
| Hypothetical protein | −9.22 | 3.54E-03 | |
|
| Hypothetical protein | −8.46 | 2.01E-12 | |
|
| Hypothetical protein | −8.13 | 1.59E-05 | |
|
| Hypothetical protein | −6.99 | 2.07E-06 | |
|
| Hypothetical protein | −6.81 | 5.27E-03 | |
|
| Hypothetical protein | −6.59 | 2.38E-08 | |
|
| Hypothetical protein | −6.21 | 4.89E-04 | |
|
| Hypothetical protein | −6.19 | 2.50E-03 | |
|
| Hypothetical protein | −6.01 | 1.79E-02 | |
|
| Hypothetical protein | −6.01 | 4.11E-06 | |
|
| Hypothetical protein | −5.54 | 8.50E-04 | |
|
| Hypothetical protein | −5.46 | 1.09E-05 | |
|
| Hypothetical protein | −5.04 | 5.73E-06 | |
|
| Hypothetical protein | −4.94 | 2.02E-03 | |
|
| Hypothetical protein | −4.83 | 9.23E-03 | |
|
| Hypothetical protein | −4.76 | 2.40E-05 | |
|
| Hypothetical protein | −4.75 | 3.31E-02 | |
|
| Hypothetical protein | −4.49 | 3.89E-02 | |
|
| Hypothetical protein | −4.27 | 1.17E-02 | |
|
| Hypothetical protein | −3.51 | 1.99E-02 | |
|
| Hypothetical protein | −3.38 | 2.03E-02 | |
|
| Hypothetical protein | −3.36 | 2.65E-03 | |
|
| Hypothetical protein | −3.34 | 8.21E-03 | |
|
| Hypothetical protein | −3.30 | 4.75E-02 | |
|
| Hypothetical protein | −3.21 | 3.49E-02 | |
|
| Hypothetical protein | −3.14 | 8.38E-03 | |
|
| Hypothetical protein | −3.13 | 4.52E-02 | |
|
| Hypothetical protein | −2.87 | 1.49E-02 | |
|
| Hypothetical protein | −2.77 | 2.11E-03 | |
|
| Hypothetical protein | −2.65 | 1.69E-02 | |
|
| ||||
|
| Lipoprotein | −2.90 | 2.27E-02 | |
|
| ||||
|
| Histidine kinase sensor protein | −4.55 | 2.15E-02 | |
|
| TetR family transcriptional regulator | −2.87 | 1.49E-02 | |
|
| Histidine kinase sensor protein | −2.52 | 4.03E-02 | |
|
| ||||
|
|
| ABC transporter ATP-binding protein | −7.96 | 2.03E-02 |
|
| ||||
|
|
| Glutamyl-tRNA reductase | −6.31 | 2.78E-09 |
|
| Acyl-CoA hydrolase | −5.56 | 2.23E-02 | |
|
|
| Gamma-glutamyl kinase | −3.97 | 2.53E-02 |
|
|
| Porphobilinogen deaminase | −3.74 | 1.82E-04 |
|
|
| 2-isopropylmalate synthase | −3.34 | 1.93E-03 |
|
|
| Uroporphyrinogen decarboxylase | −3.33 | 3.41E-03 |
|
|
| Enoyl-CoA hydratase | −3.28 | 2.26E-02 |
|
|
| S-adenosylmethionine decarboxylase like protein | −3.28 | 1.19E-03 |
|
|
| 6,7-dimethyl-8-ribityllumazine synthase | −2.86 | 3.06E-02 |
|
|
| Glutamate-1-semialdehyde aminotransferase | −2.44 | 1.49E-02 |
|
|
| S-adenosylmethionine decarboxylase proenzyme | −2.31 | 1.99E-02 |
|
|
| Delta-aminolevulinic acid dehydratase | −2.29 | 3.57E-02 |
|
| ||||
|
|
| ATP-dependent protease | −4.71 | 1.11E-02 |
|
|
| Pirin | −2.83 | 6.60E-03 |
|
|
| Elongation factor EF-G | −2.71 | 3.53E-03 |
|
| Glycosyltransferase | −2.65 | 4.04E-02 | |
Gene designations and protein product descriptions are based on those of [11], [12] and the L. interrogans sv. Copenhageni Genome Project database (http://aeg.lbi.ic.unicamp.br/world/lic/) except where indicated.
Annotation based on Setubal et al. [47].
Candidate small non-coding RNAs identified by RNA-Seq.
| Transcript | Homology | E-value | Chr | Genome Coordinates | sRNA size | Validated | |
|
| tmRNA | 1.50E-62 | 1 | 175,606 | 175,960 | 355 | + |
|
| PyrR binding site | 1.50E-04 | 1 | 263,598 | 264,013 | 416 | + |
|
| − | 1 | 849,634 | 849,900 | 267 | + | |
|
| − | 1 | 2,109,156 | 2,109,444 | 289 | + | |
|
| Cobalamin | 3E-25 | 1 | 2,878,556 | 2,878,746 | 191 | − |
|
| RNaseP | 5.50E-31 | 1 | 3,031,445 | 3,031,846 | 402 | + |
|
| − | 1 | 4,015,037 | 4,015,237 | 201 | − | |
|
| Cobalamin | 6.80E-19 | 2 | 159,019 | 159,243 | 225 | + |
|
| − | 2 | 242,735 | 243,092 | 358 | + | |
|
| − | 2 | 246,062 | 246,477 | 416 | + | |
|
| − | 2 | 348,946 | 349,168 | 223 | − | |
Predicted sRNAs are annotated according to the genome of L. interrogans sv. Copenhageni (LIC) chromosome number followed by non-coding RNA designation as included in Supplementary Table S2.
Homology to known sRNA families is indicated as is the E-value when transcripts were searched against the Rfam database.
Expression was validated by reverse-transcriptase PCR in L. interrogans sv. Copenhageni strain RJ16441.
Figure 6IGB viewer of candidate sRNA LIC1nc80.
LICnc80 was identified as an area of high transcriptional activity within an intergenic region of the genome of L. interrogans sv. Copenhageni Fiocruz L1-130. Expression data for leptospires cultivated in DMCs (green) compared to those cultivated in vitro (IV, red) are indicated on the plus strand of the genome. Annotated genes on the relevant chromosome and nucleotide co-ordinates are indicated. The vertical “read count” scale is 0–100.
Figure 7Validation of comparative RNA-Seq analysis.
(A) qRT-pCR analysis of representative genes identified by RNA-Seq. Values represent the average transcript copy numbers for each gene normalized per lipL32 transcript. Bars indicate the standard error of the mean (SEM). Results presented are mean values from at least 3 biologically-independent samples of leptospires for each growth condition. The fold-regulation for each gene determined by RNA-Seq is indicated in parentheses. The fold-regulation between in vitro- (IV) and DMC-cultivated leptospires determined by qRT-PCR are indicated. P values were calculated using an unpaired t-test. (B) Correlation coefficient (R2) between RNA-Seq and qRT-PCR data.